Eliquis 5 mg tablets are an important medication widely used for the prevention and treatment of various thromboembolic disorders. In the UK, they are often prescribed to patients who require anticoagulation therapy due to conditions such as atrial fibrillation or deep vein thrombosis.
What is Eliquis?
Eliquis, known generically as apixaban, belongs to a class of drugs called direct oral anticoagulants (DOACs). These medications work by inhibiting factor Xa, a key component in the blood coagulation process. This action helps reduce the risk of stroke and other complications associated with blood clots.
Uses of Eliquis 5 mg Tablets
The main indications for eliquis 5 mg tablets UK include:
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Reduction in the risk of recurrence of DVT and PE following initial treatment.
Dosage and Administration
The typical dose of eliquis 5 mg is taken twice daily. However, the exact dosage may vary based on individual patient characteristics, renal function, and concurrent medications. It is crucial for patients to follow their healthcare provider’s instructions carefully when taking this medication.
Side Effects and Precautions
- Bleeding complications
- Nausea and vomiting
- Fatigue
Patients should contact their healthcare professional if they notice any unusual bleeding or eliquis 5 mg tablets uk bruising, or if they have any concerns regarding their treatment.
Cost and Availability in the UK
Eliquis 5 mg tablets UK can be obtained through pharmacies with a valid prescription. Prices may vary depending on the pharmacy, but it’s essential to check with your provider if you have any questions about costs and insurance coverage.
Where to Buy Eliquis
Patients looking to purchase eliquis 5 mg tablets should consult their healthcare provider for advice. For more information about this medication, visit NHS Eliquis Information.
In conclusion, eliquis 5 mg is a significant option for managing anticoagulation therapy in the UK, providing patients with effective protection against the risks associated with blood clots.